Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation

We did not observe a difference in clinical outcomes between the treated and observed groups of patients with HHV-6B reactivation following haploidentical alloHCT. With the rising use of haploidentical transplant and post-transplant cyclophosphamide GVHD prevention platforms, prospective studies are needed to further characterize the risk and outcomes associated with HHV-6B reactivation and therapy.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2024-09-26
DOI
https://doi.org/10.1093/ofid/ofae564
Citations
3
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation

Guy Handley, Rawan Faramand, Michael David Jain, Jongphil Kim et al.
3 citations
Open Forum Infectious Diseases
Cytomegalovirus and herpesvirus research
1.16
article

Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation

Guy Handley, Rawan Faramand, Michael David Jain, Jongphil Kim, Aleksandr Lazaryan, Abu‐Sayeef Mirza, Farhad Khimani, Hany Elmariah, Frederick Lundry Locke, H.D. Liu, Gabriel Domínguez-Maldonado, Aliyah Baluch, Omar Castañeda Puglianini, Doris K. Hansen, Eva Eliassen, Ciara L. Freeman, Taiga Nishihori, Nelli Bejanyan, Anthony J Febres-Aldana, Fabiana Perna, Olga Klinkova, Asmita Mishra, Yanina Pasikhova, Melissa Alsina, Joseph A. Pidala, Lia Perez, Michael L. Nieder, Amanda Yepes, Leonel Ochoa
article en
3 citations

Abstract

We did not observe a difference in clinical outcomes between the treated and observed groups of patients with HHV-6B reactivation following haploidentical alloHCT. With the rising use of haploidentical transplant and post-transplant cyclophosphamide GVHD prevention platforms, prospective studies are needed to further characterize the risk and outcomes associated with HHV-6B reactivation and therapy.

Open Forum Infectious DiseasesVol. 11(10)
University of South Florida (US), Moffitt Cancer Center (US)
Openalex Percentile: Top 20%
Cytomegalovirus and herpesvirus research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.